{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:09:48Z","timestamp":1787627388188,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejmech.2020.112674","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T17:59:28Z","timestamp":1596995968000},"page":"112674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2030-2335","authenticated-orcid":false,"given":"JoLynn B.","family":"Giancola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8353-4985","authenticated-orcid":false,"given":"Therese","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Haraczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7915-3530","authenticated-orcid":false,"given":"Jenny","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Rais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Coggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-9878","authenticated-orcid":false,"given":"Gianluigi","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-9474","authenticated-orcid":false,"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2020.112674_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2105\/AJPH.2016.303627","article-title":"Recent increases in cocaine-related overdose deaths and the role of opioids","volume":"107","author":"McCall Jones","year":"2017","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.ejmech.2020.112674_bib2","author":"Drug Enforcment Administration National Drug Threat Assessment"},{"key":"10.1016\/j.ejmech.2020.112674_bib3","author":"Kariisa"},{"key":"10.1016\/j.ejmech.2020.112674_bib4","author":"Gladden"},{"issue":"9","key":"10.1016\/j.ejmech.2020.112674_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2020.112674_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","article-title":"SLC6 transporters: structure, function, regulation, disease association and therapeutics","volume":"34","author":"Pramod","year":"2013","journal-title":"Mol. Aspect. Med."},{"issue":"7","key":"10.1016\/j.ejmech.2020.112674_bib7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nn.2146","article-title":"The binding sites for cocaine and dopamine in the dopamine transporter overlap","volume":"11","author":"Beuming","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112674_bib8","doi-asserted-by":"crossref","first-page":"10652","DOI":"10.1038\/ncomms10652","article-title":"Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain","volume":"7","author":"Freyberg","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112674_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","article-title":"Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings","volume":"129","author":"Panenka","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112674_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1874473711205030227","article-title":"Mechanism of action of methamphetamine within the catecholamine and serotonin areas of the central nervous system","volume":"5","author":"Chiu","year":"2012","journal-title":"Curr. Drug Abuse Rev."},{"issue":"7","key":"10.1016\/j.ejmech.2020.112674_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/15563650.2010.516263","article-title":"Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation","volume":"48","author":"Seger","year":"2010","journal-title":"Clin. Toxicol."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2020.112674_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2004.07.010","article-title":"Rapid regulation of the dopamine transporter: role in stimulant addiction?","volume":"47","author":"Zahniser","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2020.112674_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.2009.05148.x","article-title":"Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse","volume":"1187","author":"Schmitt","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2020.112674_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)57007-4","article-title":"Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors","volume":"57","author":"Tanda","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112674_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.ejmech.2020.112674_bib16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41386-019-0366-z","article-title":"Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders","volume":"44","author":"Newman","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ejmech.2020.112674_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.111.191056","article-title":"Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates","volume":"346","author":"Schmitt","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112674_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acschemneuro.7b00374","article-title":"An overview of the clinical uses, pharmacology, and safety of modafinil","volume":"9","author":"Murillo-Rodriguez","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112674_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","article-title":"A\u00a0double-blind, placebo-controlled trial of modafinil (200 mg\/day) for methamphetamine dependence","volume":"104","author":"Shearer","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.ejmech.2020.112674_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A\u00a0double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2020.112674_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112674_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A\u00a0double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J.\u00a0Subst. Abuse Treat."},{"issue":"23","key":"10.1016\/j.ejmech.2020.112674_bib23","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1021\/acs.jmedchem.6b01373","article-title":"Novel and high affinity 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues as atypical dopamine transporter inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112674_bib24","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/jm401754x","article-title":"Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues","volume":"57","author":"Okunola-Bakare","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112674_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/ml1002025","article-title":"Structure-activity relationships at the monoamine transporters for a novel series of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) analogues","volume":"2","author":"Cao","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"issue":"22","key":"10.1016\/j.ejmech.2020.112674_bib26","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1021\/acs.jmedchem.7b01313","article-title":"Heterocyclic analogues of modafinil as novel, atypical dopamine transporter inhibitors","volume":"60","author":"Kalaba","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112674_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/acs.jmedchem.9b01938","article-title":"Structure-activity relationships of novel thiazole-based modafinil analogues acting at monoamine transporters","volume":"63","author":"Kalaba","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112674_bib28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fphar.2019.00682","article-title":"The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding","volume":"10","author":"Rotolo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112674_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fnbeh.2017.00222","article-title":"A\u00a0novel dopamine transporter inhibitor CE-123 improves cognitive flexibility and maintains impulsivity in healthy male rats","volume":"11","author":"Nikiforuk","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112674_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbr.2018.01.032","article-title":"A\u00a0daily single dose of a novel modafinil analogue CE-123 improves memory acquisition and memory retrieval","volume":"343","author":"Kristofova","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2020.112674_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuropharm.2017.12.006","article-title":"Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats","volume":"131","author":"Tunstall","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.ejmech.2020.112674_bib32","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/acschemneuro.8b00340","article-title":"Effects of ( R)-Modafinil and modafinil analogues on dopamine dynamics assessed by voltammetry and microdialysis in the mouse nucleus accumbens shell","volume":"10","author":"Keighron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112674_bib33","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1021\/acs.jmedchem.9b01188","article-title":"Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinyl alkyl alicyclic amines at the dopamine transporter: functionalizing the terminal nitrogen affects affinity, selectivity, and metabolic stability","volume":"63","author":"Slack","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112674_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2020.112674_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.117.241109","article-title":"Sigma receptor effects of N-substituted benztropine analogs: implications for antagonism of cocaine self-administration","volume":"362","author":"Hiranita","year":"2017","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"13","key":"10.1016\/j.ejmech.2020.112674_bib36","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/jm030008u","article-title":"Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4\u2019-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents","volume":"46","author":"Cao","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"issue":"4\u20137","key":"10.1016\/j.ejmech.2020.112674_bib37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1081\/NCN-100002493","article-title":"The design and synthesis of purine inhibitors of CDK2. III. Nucleosides Nucleotides","volume":"20","author":"Shum","year":"2001","journal-title":"Nucleic Acids"},{"issue":"7","key":"10.1016\/j.ejmech.2020.112674_bib38","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.ejmech.2011.04.016","article-title":"Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position","volume":"46","author":"Nguyen","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112674_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cmdc.201402502","article-title":"Evaluation of tert-butyl isosteres: case studies of physicochemical and pharmacokinetic properties, efficacies, and activities","volume":"10","author":"Westphal","year":"2015","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.ejmech.2020.112674_bib40","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1021\/jm300094u","article-title":"Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active gamma-secretase inhibitor","volume":"55","author":"Stepan","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2020.112674_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt.205","article-title":"Late sodium current block for drug-induced long QT syndrome: results from a prospective clinical trial","volume":"99","author":"Johannesen","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ejmech.2020.112674_bib42","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/ejn.14256","article-title":"Distinct effects of (R)-modafinil and its (R)- and (S)-fluoro-analogs on mesolimbic extracellular dopamine assessed by voltammetry and microdialysis in rats","volume":"50","author":"Keighron","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112674_bib43","doi-asserted-by":"crossref","first-page":"107446","DOI":"10.1016\/j.neuropharm.2018.11.034","article-title":"Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors","volume":"161","author":"Zanettini","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2020.112674_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.pharmtox.41.1.443","article-title":"Metabolism of fluorine-containing drugs","volume":"41","author":"Park","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"23","key":"10.1016\/j.ejmech.2020.112674_bib45","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112674_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"issue":"16","key":"10.1016\/j.ejmech.2020.112674_bib47","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/acs.jmedchem.6b00860","article-title":"Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the D3R crystal structure: new leads for opioid dependence treatment","volume":"59","author":"Kumar","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112674_bib48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"6","key":"10.1016\/j.ejmech.2020.112674_bib49","article-title":"Species differences in the pharmacokinetic parameters of cytochrome P450 probe substrates between experimental animals, such as mice, rats, dogs, monkeys, and microminipigs, and humans","volume":"5","author":"Sakai","year":"2014","journal-title":"J.\u00a0Drug Metabol. Toxicol."},{"key":"10.1016\/j.ejmech.2020.112674_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropharm.2018.01.042","article-title":"Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays","volume":"133","author":"Yano","year":"2018","journal-title":"Neuropharmacology"},{"issue":"20","key":"10.1016\/j.ejmech.2020.112674_bib51","doi-asserted-by":"crossref","first-page":"9061","DOI":"10.1021\/acs.jmedchem.9b00607","article-title":"Investigation of novel primary and secondary pharmacophores and 3-substitution in the linking chain of a series of highly selective and bitopic dopamine D3 receptor antagonists and partial agonists","volume":"62","author":"Shaik","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2020.112674_bib52","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1124\/dmd.112.046482","article-title":"Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice","volume":"40","author":"Rais","year":"2012","journal-title":"Drug Metab. Dispos."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420306462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420306462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:17:57Z","timestamp":1759328277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420306462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":52,"alternative-id":["S0223523420306462"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112674","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112674"}}